Due to recent formulary changes, patients covered by Medicare, Medicaid and many major commercial insurance plans should have more access and coverage for their Mitigare® (Colchicine) 0.6 mg Capsules and Generic Colchicine Capsules prescriptions.
Click on our announcements below to find out more about each coverage update.
*Managed Markets Insight & Technology, LLC database and formulary status as of January 2021.
Recent Announcements
All the following are Effective January 1, 2021
Mitigare® (Colchicine) 0.6 mg Capsules are now Preferred on the Humana MEDICARE Part D formulary and Humana Commercial formulary.
Details: Colcrys® (colchicine, USP) 0.6 mg tablets, colchicine tablets, and colchicine capsules require prior authorization on the Humana MEDICARE Part D formulary.
Mitigare® (Colchicine) 0.6 mg Capsules are now Preferred on the CVS SilverScript® MEDICARE Part D formulary.
Details: Colcrys® (colchicine, USP) 0.6 mg tablets and colchicine capsules require prior authorization on the CVS SilverScript® MEDICARE Part D formulary.
Mitigare® (Colchicine) 0.6 mg Capsules are now a Preferred Agent on the Cigna MEDICARE Part D formulary.
Mitigare® (Colchicine) 0.6 mg Capsules are now Preferred on the BCBS-AZ Blue Medicare RX formulary.
Mitigare® (Colchicine) 0.6 mg Capsules are now a Preferred on Wisconsin Medicaid Formulary.
Details: Colcrys® (colchicine, USP) 0.6 mg tablets, colchicine tablets, and colchicine capsules require prior authorization on Wisconsin Medicaid Formulary.
Mitigare® (Colchicine) 0.6 mg Capsules are now a Preferred Agent on the Aetna MEDICARE Part D formulary.
Colcrys® is a registered trademark of Takeda Pharmaceuticals America, Inc.